NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%
NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%

JPMorgan Downgrades Indian Equities Amid Elevated Valuations and Energy Shocks

Global brokerage JPMorgan has downgraded Indian equities to "neutral" from "overweight," citing elevated valuations compared to emerging market peers and pressure on earnings from energy supply shocks linked to the Iran war. This move comes a day after HSBC lowered its rating.

The brokerage warned that surging crude prices could stoke inflation and growth risks for the country, squeezing consumption and weighing on near-term corporate margins. A weakening rupee is also adding to the pressure. JPMorgan's note on Friday highlighted the potential risks associated with energy supply shocks and their impact on the Indian economy.

Targets Lowered for Nifty 50

Read also: Markets May Face Further Decline if Nifty Fails to Clear 23,600 Resistance

JPMorgan has lowered its year-end target for the benchmark Nifty 50 by 10% to 27,000. The brokerage has also cut the 50-stock index's bull case target to 30,000, down 9% from the earlier target. For the base case, the target has been cut to 27,000 from 30,000. The index's bear case aim was trimmed to 20,500 from 24,000.

Nifty and Sensex Performances

The Nifty and Sensex have fallen 8.5% and 10% this year, respectively, and are currently trading about 9.3% and 11% lower than record highs hit in early 2026 and late 2025, respectively.

Comparative Valuations

Read also: Government Sets Aside Higher Allocation for Telecom Tech Development Fund by October

CountryPremium to MSCI Emerging Markets
India65%
Korea
Brazil
China
Mexico
South Africa

India's premium to the MSCI emerging markets has compressed to 65% from 109%, reflecting some of the re-rating. However, peers like Korea, Brazil, and China still offer cheaper entry points than India for similar or better growth.

Sector Analysts' Estimates

Sector analysts at JPMorgan cut their earnings growth estimates for financial year 2027 by 2-10% across key sectors. Consequently, they have lowered their MSCI India earnings-per-share growth for 2026 and 2027 by 2% and 1%, respectively, bringing them to 11% and 13%, according to the report.

Market Dilution and Growth Themes

The brokerage added that large domestic inflows have cushioned a record $37 billion FPI exodus, but a $64 billion pipeline in the form of IPOs and QIPs, along with promoter sales, are diluting existing holders and capping upside. India also lacks meaningful exposure to high-growth themes such as AI, data centers, robotics, and semiconductors, which could limit earnings growth compared to emerging market peers with a stronger presence in these segments.

Near-term Outlook

While JPMorgan said the country's long-term growth story is still intact, the near-term outlook has weakened. Subdued monsoon is also said to be an added risk to their outlook.

Sector Recommendations

It remains "overweight" on sectors including financials, materials, consumer discretionary, hospitals, defense, and power, while staying "underweight" on IT and pharmaceuticals.

Investor Takeaway

Investors should be cautious and consider reducing their exposure to Indian equities due to the downgrade and potential impact on earnings.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.